Skip to main content
PMC home page
Gut logoLink to Gut
. 1995 Jan;36(1):12–16. doi: 10.1136/gut.36.1.12

Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole.

R P Logan 1, M M Walker 1, J J Misiewicz 1, P A Gummett 1, Q N Karim 1, J H Baron 1
PMCID: PMC1382345  PMID: 7890214

Abstract

Omeprazole is a powerful inhibitor of gastric acid and may suppress Helicobacter pylori by effecting the pKa of H pylori urease, by altering the pattern of infection, or by promoting overgrowth of other bacteria. At routine endoscopy H pylori was detected by histology and culture before and after four weeks' treatment with omeprazole, 40 mg each morning. A 13C-urea breath test was also done at t = 0, 2, 4, and 6 weeks. Thirty nine patients with duodenal ulcer (n = 25) or reflux oesophagitis (n = 14) were studied, of whom 29 of 39 had H pylori infection. During omeprazole treatment, 13C-urea breath test values fell significantly--mean (SEM) values before treatment and at four weeks were 23.0 (2.1) and 15.5 (2.7) per mil respectively, p < 0.001. Before treatment H pylori was seen in 28 of 29 antral, 29 of 29 corpus, and 28 of 29 fundic biopsy specimens. After four weeks of omeprazole treatment, the histological density of H pylori in the antrum and corpus was reduced (p < 0.001), while that in the fundus was increased. The migration of H pylori from the antrum to the fundus was associated with a corresponding decrease in the activity of antral gastritis. H pylori was not seen in antral biopsy specimens from 12 of 29 patients whose median excess delta 13CO2 excretion fell from 23.0 to 9.9 per mil. In the body mucosa, 26 of 29 specimens were still positive for H pylori and there was no significant change in the gastritis type. Two weeks after finishing treatment, the mean (SEM) excess delta 13CO2 excretion returned to levels before treatment. Omeprazole decreases antral H pylori colonisation but increases that in the fundus. The changes in the intragastric distribution of the organism are associated with concomitant changes in the activity of gastritis and are matched by a progressive fall in the excretion of delta 13CO2.

Full text

PDF
16

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archimandritis A., Tjivras M., Davaris P., Fertakis A. Effect of omeprazole on H. pylori after two weeks of treatment. Ital J Gastroenterol. 1991 Jul-Aug;23(6):357–358. [PubMed] [Google Scholar]
  2. Axon A. R. Duodenal ulcer: the villain unmasked? BMJ. 1991 Apr 20;302(6782):919–921. doi: 10.1136/bmj.302.6782.919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Biasco G., Miglioli M., Barbara L., Corinaldesi R., di Febo G. Omeprazole, Helicobacter pylori, gastritis, and duodenal ulcer. Lancet. 1989 Dec 9;2(8676):1403–1403. doi: 10.1016/s0140-6736(89)92021-7. [DOI] [PubMed] [Google Scholar]
  4. Cleaning and disinfection of equipment for gastrointestinal flexible endoscopy: interim recommendations of a Working Party of the British Society of Gastroenterology. Gut. 1988 Aug;29(8):1134–1151. doi: 10.1136/gut.29.8.1134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eaton K. A., Brooks C. L., Morgan D. R., Krakowka S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun. 1991 Jul;59(7):2470–2475. doi: 10.1128/iai.59.7.2470-2475.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ghelani A. M., Hale S., Coleman H., Radziwonik H., Robertson C., Atkinson M. Lack of in vitro activity of omeprazole against Campylobacter pylori. J Clin Pathol. 1990 Feb;43(2):171–172. doi: 10.1136/jcp.43.2.171-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Graham D. Y., Lew G. M., Evans D. G., Evans D. J., Jr, Klein P. D. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. Ann Intern Med. 1991 Aug 15;115(4):266–269. doi: 10.7326/0003-4819-115-4-266. [DOI] [PubMed] [Google Scholar]
  8. Hui W. M., Lam S. K., Ho J., Lai C. L., Lok A. S., Ng M. M., Lau W. Y., Branicki F. J. Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. Dig Dis Sci. 1991 May;36(5):577–582. doi: 10.1007/BF01297022. [DOI] [PubMed] [Google Scholar]
  9. Hunt R. H., Howden C. W., Jones D. B., Burget D. W., Kerr G. D. The correlation between acid suppression and peptic ulcer healing. Scand J Gastroenterol Suppl. 1986;125:22–31. doi: 10.3109/00365528609093814. [DOI] [PubMed] [Google Scholar]
  10. Iwahi T., Satoh H., Nakao M., Iwasaki T., Yamazaki T., Kubo K., Tamura T., Imada A. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother. 1991 Mar;35(3):490–496. doi: 10.1128/aac.35.3.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McColm A. A., Bagshaw J. A., O'Malley C. F. Development of a 14C-urea breath test in ferrets colonised with Helicobacter mustelae: effects of treatment with bismuth, antibiotics, and urease inhibitors. Gut. 1993 Feb;34(2):181–186. doi: 10.1136/gut.34.2.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mobley H. L., Hausinger R. P. Microbial ureases: significance, regulation, and molecular characterization. Microbiol Rev. 1989 Mar;53(1):85–108. doi: 10.1128/mr.53.1.85-108.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nagata K., Satoh H., Iwahi T., Shimoyama T., Tamura T. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells. Antimicrob Agents Chemother. 1993 Apr;37(4):769–774. doi: 10.1128/aac.37.4.769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rauws E. A., Langenberg W., Houthoff H. J., Zanen H. C., Tytgat G. N. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology. 1988 Jan;94(1):33–40. [PubMed] [Google Scholar]
  15. Stolte M., Bethke B. Elimination of Helicobacter pylori under treatment with omeprazole. Z Gastroenterol. 1990 Jun;28(6):271–274. [PubMed] [Google Scholar]
  16. Vigneri S., Termini R., Scialabba A., Pisciotta G., Di Mario F. Omeprazole therapy modifies the gastric localization of Helicobacter pylori. Am J Gastroenterol. 1991 Sep;86(9):1276–1276. [PubMed] [Google Scholar]
  17. Weil J., Bell G. D., Powell K., Morden A., Harrison G., Gant P. W., Jones P. H., Trowell J. E. Omeprazole and Helicobacter pylori: temporary suppression rather than true eradication. Aliment Pharmacol Ther. 1991 Jun;5(3):309–313. doi: 10.1111/j.1365-2036.1991.tb00032.x. [DOI] [PubMed] [Google Scholar]
  18. Weiner A. J., Kuo G., Bradley D. W., Bonino F., Saracco G., Lee C., Rosenblatt J., Choo Q. L., Houghton M. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet. 1990 Jan 6;335(8680):1–3. doi: 10.1016/0140-6736(90)90134-q. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES